Brief: Xintela Receives 'Intention To Grant' Decision From European Patent Office
Oct 29 (Reuters) - Xintela AB XINT.ST :
* XINTELA RECEIVES 'INTENTION TO GRANT' DECISION FROM
EUROPEAN
PATENT OFFICE FOR STEM CELL PRODUCT XSTEM
* EPO WILL GRANT PATENT AFTER FULFILLMENT OF CERTAIN
ADMINISTRATIVE STEPS
* GRANTED PATENT WILL CONFER PROTECTION FOR XINTELA'S STEM
CELL
PRODUCT XSTEM IN EUROPE UNTIL 2038
Source text for Eikon: ID:nBQN2q4Hyd
Further company coverage: XINT.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Xintela AB
See all newsBrief: Xintela To Raise SEK 30 Mln Via Convertible Loan From Flerie Invest
Advisory: Alerts on Xintela's phase I/IIa XSTEM results withdrawn
Brief: Xintela Q1 2026 Loss Before Tax SEK 11.8 Mln
Brief: Xintela Study Finds XSTEM Treatment Safe, Well Tolerated
Brief: Xintela Gets U.S. Patent For Xstem Treatment Of Difficult-To-Heal Wounds, Skin Defects